Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Sep 16;138(11):996-999.
doi: 10.1182/blood.2021012790.

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)

Finn-Ole Paulsen  1 , Christoph Schaefers  1 , Florian Langer  1 , Christian Frenzel  1 , Ulrich Wenzel  2 , Felicitas E Hengel  2 , Carsten Bokemeyer  1 , Christoph Seidel  1
Affiliations
Clinical Trial

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)

Finn-Ole Paulsen et al. Blood. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Platelet count responses to treatment. Patients received glucocorticoids (all patients), intravenous immunoglobulins (patients 1 and 2), and thrombopoietin receptor agonist (patient 2).
See this image and copyright information in PMC

References

    1. Park M, Cook AR, Lim JT, Sun Y, Dickens BL.. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020; 9(4):967. - PMC - PubMed
    1. Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM.. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep. 2021;8:871-879. - PMC - PubMed
    1. Folegatti PM, Ewer KJ, Aley PK, et al. ; Oxford COVID Vaccine Trial Group . Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249): 467-478. - PMC - PubMed
    1. Ramasamy MN, Minassian AM, Ewer KJ, et al. ; Oxford COVID Vaccine Trial Group . Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979-1993. - PMC - PubMed
    1. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S.. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092-2101. - PMC - PubMed

MeSH terms